GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹7,888 Cr | ₹7,157 Cr | ₹6,788 Cr | ₹6,015 Cr | ₹5,234 Cr |
What is the latest Profit & Loss Account Balance ratio of GLAND PHARMA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹7,888 Cr |
| Mar2025 | ₹7,157 Cr |
| Mar2024 | ₹6,788 Cr |
| Mar2023 | ₹6,015 Cr |
| Mar2022 | ₹5,234 Cr |
How is Profit & Loss Account Balance of GLAND PHARMA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,888 Cr | 10.21 | |
| Mar2025 | ₹7,157 Cr | 5.44 | |
| Mar2024 | ₹6,788 Cr | 12.84 | |
| Mar2023 | ₹6,015 Cr | 14.92 | |
| Mar2022 | ₹5,234 Cr | - | |
Compare Profit & Loss Account Balance of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹48,871.4 Cr | 1.3% | 4.2% | 44% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 1.3% |
4.2% |
44% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses